Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rohde

Showing results (271-280 of 288) with videos related to

Pageof 29
Sort By:
Academic Pathology|November 19, 2024
Social media in pathology and laboratory medicine: A systematic reviewAllyson Flippo, Bhakti Dixit, Casey P Schukow, et al.
American Heart Journal|December 11, 2017
Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trialPriscila Raupp da Rosa, Luis E Rohde, Madeni Doebber, et al.
European Journal of Heart Failure|December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HFJames P Curtain, Alice M Jackson, Li Shen, et al.
Circulation. Heart Failure|March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF AnalysisLuis E Rohde, Brian L Claggett, Emil Wolsk, et al.
European Journal of Cancer Care|August 5, 2017
The international phase 4 validation study of the EORTC QLQ-SWB32: A stand-alone measure of spiritual well-being for people receiving palliative care for cancerB Vivat, T E Young, J Winstanley, et al.
European Heart Journal|August 20, 2019
Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trialLuis E Rohde, Marciane M Rover, Jose A Figueiredo Neto, et al.
Targeted Oncology|November 9, 2020
Developing Symptom Lists for People with Cancer Treated with Targeted TherapiesSamantha C Sodergren, Sally J Wheelwright, Deborah Fitzsimmons, et al.
European Heart Journal|January 12, 2023
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fractionJames P Curtain, Carly Adamson, Toru Kondo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 13, 2019
A systematic review of quality of life research in medicine and health sciencesK Haraldstad, A Wahl, R Andenæs, et al.
American Heart Journal|June 5, 2025
Conduction system pacing vs biventricular resynchronization in heart failure with reduced ejection fraction and left bundle branch block: Rationale and design of the PhysioSync-HF TrialAndré Zimerman, Alexander Dal Forno, Luis E Rohde, et al.
Pageof 29

Showing results (271-280 of 288) with videos related to

Sort By:
Pageof 29
Academic Pathology|November 19, 2024
Social media in pathology and laboratory medicine: A systematic reviewAllyson Flippo, Bhakti Dixit, Casey P Schukow, et al.
American Heart Journal|December 11, 2017
Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trialPriscila Raupp da Rosa, Luis E Rohde, Madeni Doebber, et al.
European Journal of Heart Failure|December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HFJames P Curtain, Alice M Jackson, Li Shen, et al.
Circulation. Heart Failure|March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF AnalysisLuis E Rohde, Brian L Claggett, Emil Wolsk, et al.
European Journal of Cancer Care|August 5, 2017
The international phase 4 validation study of the EORTC QLQ-SWB32: A stand-alone measure of spiritual well-being for people receiving palliative care for cancerB Vivat, T E Young, J Winstanley, et al.
European Heart Journal|August 20, 2019
Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trialLuis E Rohde, Marciane M Rover, Jose A Figueiredo Neto, et al.
Targeted Oncology|November 9, 2020
Developing Symptom Lists for People with Cancer Treated with Targeted TherapiesSamantha C Sodergren, Sally J Wheelwright, Deborah Fitzsimmons, et al.
European Heart Journal|January 12, 2023
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fractionJames P Curtain, Carly Adamson, Toru Kondo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 13, 2019
A systematic review of quality of life research in medicine and health sciencesK Haraldstad, A Wahl, R Andenæs, et al.
American Heart Journal|June 5, 2025
Conduction system pacing vs biventricular resynchronization in heart failure with reduced ejection fraction and left bundle branch block: Rationale and design of the PhysioSync-HF TrialAndré Zimerman, Alexander Dal Forno, Luis E Rohde, et al.
Pageof 29